These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2099187)

  • 1. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
    Vaidyanathan G; Zalutsky MR
    Bioconjug Chem; 1990; 1(6):387-93. PubMed ID: 2099187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination.
    Garg S; Garg PK; Zalutsky MR
    Bioconjug Chem; 1991; 2(1):50-6. PubMed ID: 1878411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
    Garg PK; Garg S; Zalutsky MR
    Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.
    Vaidyanathan G; White BJ; Affleck DJ; Zhao XG; Welsh PC; McDougald D; Choi J; Zalutsky MR
    Bioorg Med Chem; 2012 Dec; 20(24):6929-39. PubMed ID: 23159039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
    Zalutsky MR; Narula AS
    Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein radiohalogenation: observations on the design of N-succinimidyl ester acylation agents.
    Vaidyanathan G; Zalutsky MR
    Bioconjug Chem; 1990; 1(4):269-73. PubMed ID: 2096920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability.
    Garg PK; Slade SK; Harrison CL; Zalutsky MR
    Int J Rad Appl Instrum B; 1989; 16(7):669-73. PubMed ID: 2613522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody F(ab')2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: in vivo comparison of iodinated and astatinated fragments.
    Vaidyanathan G; Affleck D; Zalutsky MR
    Nucl Med Biol; 1994 Jan; 21(1):105-10. PubMed ID: 9234271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
    Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
    Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate.
    Vaidyanathan G; Zalutsky MR
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):275-81. PubMed ID: 1629016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of succinimidyl [(125)I]iodobenzoate with iodogen iodination methods to study pharmacokinetics and ADME of biotherapeutics.
    Chen J; Wang M; Joyce A; DeFranco D; Kavosi M; Xu X; O'Hara DM
    Pharm Res; 2014 Oct; 31(10):2810-21. PubMed ID: 24844406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
    Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.
    Garg PK; Archer GE; Bigner DD; Zalutsky MR
    Int J Rad Appl Instrum A; 1989; 40(6):485-90. PubMed ID: 2551846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods.
    Garg PK; Alston KL; Zalutsky MR
    Bioconjug Chem; 1995; 6(4):493-501. PubMed ID: 7578370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
    Zalutsky MR; Narula AS
    Int J Rad Appl Instrum A; 1987; 38(12):1051-5. PubMed ID: 2828275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
    Garg S; Garg PK; Zhao XG; Friedman HS; Bigner DD; Zalutsky MR
    Nucl Med Biol; 1993 Oct; 20(7):835-42. PubMed ID: 8241995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
    Vaidyanathan G; Zalutsky MR
    Nat Protoc; 2006; 1(2):707-13. PubMed ID: 17406300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
    Reist CJ; Garg PK; Alston KL; Bigner DD; Zalutsky MR
    Cancer Res; 1996 Nov; 56(21):4970-7. PubMed ID: 8895752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.